CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in REPL — Replimune Group, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in REPL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$4,679,956
-$1,034,334 QoQ
Shares Held
611,759
+4.1% QoQ
Ownership
0.729%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REPL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $6,182,986,350 across 288 Biotechnology names. REPL ranks #135 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,920,871 | $857,745,736 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
804,508 | $621,595,061 | |
| 3 | MRNA |
Moderna, Inc.
|
4,734,356 | $240,505,284 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
673,356 | $222,793,299 | |
| 5 | INSM |
INSMED Inc
|
1,069,390 | $174,866,652 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
1,735,476 | $168,775,041 | |
| 7 | INCY |
Incyte Corp
|
1,729,102 | $162,743,080 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,976,094 | $146,744,740 |
All Filings in REPL
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,679,956 | 611,759 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $5,714,290 | 587,890 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,159,526 | 515,400 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $5,138,884 | 553,163 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $5,382,448 | 552,046 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $6,156,699 | 508,398 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $5,313,375 | 484,797 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $3,890,691 | 432,299 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $3,420,484 | 418,664 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $3,388,371 | 401,942 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $6,472,884 | 378,310 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $6,616,446 | 284,946 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $5,238,891 | 296,653 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $7,060,494 | 259,577 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $4,356,184 | 252,240 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,669,628 | 209,933 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $3,665,082 | 215,847 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $5,661,027 | 208,894 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $6,083,787 | 205,256 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $6,965,315 | 181,294 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $5,300,166 | 173,719 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $6,295,856 | 165,029 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $3,125,126 | 135,757 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,012,836 | 40,758 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $323,965 | 32,494 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||